← Leaderboards
Noha Abdelwahab Hassan Ali Hassan
University Of Tx Md Anderson Can Ctr
$569,340
Attributed
$569,340
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $113.9K · FY2021–25$200K$150K$100K$50K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$569,340 · 1
By mechanism
K01$569,340 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Michael Davies$11,575,720
- Kathrin Milbury$8,852,386
- Hoda J. Badr$6,550,695
- Roza Insafetdinovna Nurieva$10,025,772
- David Hui$7,552,634
Others in their field
Other Emerging Leaders on “Career Development”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Prasant Mohapatra · University Of California At Davis$41,945,816
- Gary Kobinger · University Of Texas Med Br Galveston$34,500,000
- Eric C Palm · Florida State University$31,951,397
- Ross D McDonald · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
Research focus
Career DevelopmentAdjuvantCancer SurvivorCancer SurvivorshipAdverse EventAdverse Event RiskAdvisory CommitteesAcute ToxicityAcuteCancer PatientAssociated SymptomAutoimmuneAutoimmune DiseasesAutoimmunityBehavioralBehavioral SciencesBenefits And RisksAdjuvant TherapyBiological Response ModifiersAdverse EffectsBiometryAreaCancer CenterCaring
Grant awards (5)
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868
K01 · FY2025 · AI · contact PI
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868
K01 · FY2024 · AI · contact PI
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868
K01 · FY2023 · AI · contact PI
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868
K01 · FY2022 · AI · contact PI
Immune-Related Adverse Events in Melanoma Patients Receiving Adjuvant Immune Checkpoint Inhibitor Therapy$113,868
K01 · FY2021 · AI · contact PI